February 2016 | Gotoper.com

6
ASH: MPN Tumor Board: Application of Novel Agents for the Treatment of Polycythemia Vera and Myelofibrosis
December 6, 2019
Orlando, FL
CME
3.0
ASH: Medical Crossfire^®: Case Studies in AYA and Adult Acute Lymphoblastic Leukemia – How the Experts Think and Treat
December 6, 2019
Orlando, FL
CME
3.0
ASH: The Evolving Treatment Landscape for Patients With GvHD: More Options, More Decisions, Better Outcomes!
December 6, 2019
Orlando, FL
CME
3.0
ASH: Primary HLH: Diagnosis, Management, and Treatment in the 21st Century
December 6, 2019
Orlando, FL
CME
2.0
ASH: Emerging Paradigms to Address Unmet Needs in Relapsed/Refractory DLBCL
December 6, 2019
Orlando, FL
CME
3.0

14
CARDIO-ENDO-RENAL COLLABORATIVE (CERC) Clinical Connections™
Expires on
Dec 14, 2019
CME
2.0
4th Annual International Congress on Immunotherapies in Cancer^®: Focus on Practice-Changing Application
December 14, 2019
New York, NY
CME
6.25
“D” Is for Diagnosis: Solving the Mystery of Lysosomal Storage Disorders
December 14, 2019
New York, NY
CME
3.0

21
Community Practice Connections™: 3rd Annual European Congress on Immunotherapies in Cancer™
Expires on
Dec 21, 2019
CME
1.5
Community Practice Connections™: Optimizing Outcomes for Patients With Acute Lymphoblastic Leukemia
Expires on
Dec 21, 2019
CME
1.5
Community Practice Connections™: Overcoming Clinical Inertia in Glioblastoma Multiforme: The Experts Weigh-In on Recent Data Sets and Next Steps to Move the Field Forward
Expires on
Dec 21, 2019
CME
1.5

30
Cancer Summaries and Commentaries™: Update from Munich: Advances in the Treatment of Lung Cancer, Genitourinary Malignancies, and Gynecologic Malignancies
Expires on
Dec 30, 2019
CME
2.25
Cancer Summaries and Commentaries™: Report from San Diego on Advances in the Treatment of MPNs
Expires on
Dec 30, 2019
CME
1.5
Cancer Summaries and Commentaries™: Report from San Diego on Advances in the Treatment of GvHD
Expires on
Dec 30, 2019
CME
1.5
Cancer Summaries and Commentaries™: Report from San Diego on Advancements in Multiple Myeloma
Expires on
Dec 30, 2019
CME
2.0
Oncology Briefings™: Managing Pneumonitis in Patients with Stage III NSCLC
Expires on
Dec 30, 2019
CME
1.5
Oncology Briefings™: Updates in Waldenström Macroglobulinemia
Expires on
Dec 30, 2019
CME
1.0
Advances In™ the Management of Chronic Immune Thrombocytopenia
Expires on
Dec 30, 2019
CME
1.0
Advances in™ Hematology: Making Sense of Recent AML Approvals and Late-Stage Compounds
Expires on
Dec 30, 2019
CME
1.5

31
Cancer Summaries and Commentaries™: Report from San Diego on Advancements in Non-Hodgkin Lymphoma
Expires on
Dec 31, 2019
CME
1.5
Cancer Summaries and Commentaries™: Report from San Diego on Advancements in CAR T-Cell Therapy
Expires on
Dec 31, 2019
CME
0.75
Hematology Briefings™: The Evolving Management Landscape for Patients With Sickle Cell Disease: Opportunities, Challenges, and Emerging Agents for Therapy
Expires on
Dec 31, 2019
CME
1.0
Advances in™ Rare Diseases: Fatty Acid Oxidation Disorders – Improving Energy Production Through Alternative Sources
Expires on
Dec 31, 2019
CME
1.5
Advances In™ Therapies for Patients with Multiple Myeloma: More Options…More Decisions…Better Outcomes
Expires on
Dec 31, 2019
CME
0.5
Medical Crossfire®: Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): Optimizing the Diagnosis and Management Through Multidisciplinary, Patient-Centered Care
Expires on
Dec 31, 2019
CME
1.5
Medical Crossfire®: Cystic Fibrosis-Related Diabetes (CFRD): A Patient-Focused Approach to Early Recognition and Proper Treatment
Expires on
Dec 31, 2019
CME
1.5
Medical Crossfire®: Changing the Paradigm in Myelodysplastic Syndromes: How Do Patient Factors Impact Treatment Decisions?
Expires on
Dec 31, 2019
CME
2.0
Clinical Briefings^™: X-Linked Hypophosphatemia: Diagnosing and Addressing the Underlying Cause of the Disease
Expires on
Dec 31, 2019
CME
1.5
Real-World Evidence to Inform Treatment and Management of ER+ Metastatic Breast Cancer
Expires on
Dec 31, 2019
CME
1.0

Archive

Oncology Briefings™: Cases and Considerations in the Treatment of Hepatocellular Carcinoma

36th Annual Miami Breast Cancer Conference®

16th Annual Winter Lung Cancer Conference™

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

35th Annual Miami Breast Cancer Conference®

22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma®

2nd Annual International Congress on Oncology Pathology™

19th Annual International Lung Cancer Congress®

New York GU™: 11th Annual Interdisciplinary Prostate Cancer Congress® and other Genitourinary Malignancies

2nd Annual School of Nursing Oncology™

36th Annual CFS®: Innovative Cancer Therapy for Tomorrow

2nd Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

December 2017

November 2017

October 2017

September 2017

August 2017

July 2017

June 2017

May 2017

April 2017

March 2017

February 2017

January 2017

December 2016

November 2016

October 2016

September 2016

August 2016

July 2016

June 2016

May 2016

April 2016

March 2016

February 2016

January 2016

December 2015

November 2015

October 2015

September 2015

August 2015

July 2015

June 2015

May 2015

April 2015

March 2015

February 2015

January 2015

December 2014

November 2014

September 2014

August 2014

Issues List

Chairman's Letter

Michael J. Hennessy

From the Editor

Debu Tripathy, MD

Breast Cancer

Clinical Utility of Emerging Molecular Diagnostics in Breast Cancer

Marie-Kristin von Wahlde, MD; Tomoko Kurita, MD; Tara Sanft, MD; Erin Hofstatter, MD; Lajos Pusztai, MD, DPhil

Ovarian Cancer

Immunotherapy in Ovarian Cancer—Where Are We Going?

Maurie Markman, MD

Colorectal Cancer

Salvage Therapy and Emerging Agents in Colorectal Cancer

Jennifer Wu, MD

Double Hit Lymphoma

Current Concepts in Double-Hit Lymphoma

Mitul Gandhi, MD; Adam M. Petrich, MD

CME/CE: Immunotherapies in Breast Cancer

Assessing the Clinical Potential for Immunotherapies in the Treatment of Breast Cancer